Doctor profile · Federal record

Dr. Shayma Kazmi, MD

Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Philadelphia, PA

  • NPI 1801919550
  • Accepts Medicare
  • MIPS 79.9 / 100 · 2023
  • 25 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1331 E Wyoming Ave
Philadelphia, PA 191243808
(215) 537-7804
fax (215) 537-7585

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
May 11, 2010
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (2)
Pennsylvania #MD437745 · New Jersey #25MA07647100

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1801919550. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,459
Distinct HCPCS
10
Medicare allowed
$235,340
HCPCS Description Services Patients Avg allowed
J1756 Injection, iron sucrose, 1 mg 5,100 12 $0
J1453 Injection, fosaprepitant, 1 mg 3,900 13 $0
99215 Established patient office or other outpatient visit, 40-54 minutes 585 192 $190
J2405 Injection, ondansetron hydrochloride, per 1 mg 224 11 $0
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 217 109 $83
36415 Insertion of needle into vein for collection of blood sample 183 117 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 157 103 $8
96413 Administration of chemotherapy into vein, 1 hour or less 134 41 $146
96372 Injection of drug or substance under skin or into muscle 99 36 $15
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 99 97 $183

In context: peer comparison

Among 48 peers in this city , average services per provider: 121. This provider delivers 95× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$32,069
Transactions
31
Manufacturers
9
Payer (manufacturer) Industry Txns Amount
JAZZ PHARMACEUTICALS INC. 15 $22,245.93
Amgen Inc. 4 $5,873.67
Takeda Pharmaceuticals U.S.A., Inc. 1 $1,977.50
AstraZeneca Pharmaceuticals LP 2 $1,477.63
Novocure Inc. 3 $301.75
Daiichi Sankyo Inc. 1 $113.13
Merck Sharp & Dohme LLC 3 $46.92
E.R. Squibb & Sons, L.L.C. 1 $17.98
Celgene Corporation 1 $14.91

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$25,472
Consulting Fee
$3,348
Travel and Lodging
$2,158
Food and Beverage
$1,092

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
465
Patients
138
Total drug cost
$872,808
Drug Type Claims Patients Total cost
Ondansetron Hcl Generic 70 48 $651
Anastrozole Generic 59 19 $1,742
Levothyroxine Sodium Generic 55 18 $360
Prochlorperazine Maleate Generic 52 38 $729
Tagrisso (Osimertinib Mesylate) Brand 35 0 $583,613
Letrozole Generic 30 0 $804
Prednisone Generic 24 0 $179
Eliquis (Apixaban) Brand 23 0 $19,639
Dexamethasone Generic 19 15 $285
Tramadol Hcl Generic 19 0 $92

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Shayma Kazmi's medical specialty?
Dr. Shayma Kazmi practices Medical Oncology Physician in Philadelphia, PA.
Where does Dr. Shayma Kazmi practice?
Dr. Shayma Kazmi practices at 1331 E Wyoming Ave, Philadelphia, PA 191243808. Office phone: 2155377804.
What is Dr. Shayma Kazmi's NPI?
Dr. Shayma Kazmi's National Provider Identifier (NPI) is 1801919550, issued by NPPES.
Does Dr. Shayma Kazmi accept Medicare assignment?
Yes. Dr. Shayma Kazmi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shayma Kazmi commonly perform?
Top Medicare-reported procedures in 2023: Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, fosaprepitant, 1 mg (HCPCS J1453); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.